Physician profile
Robert E Wear
NPI 1285716423
$1,024.97
in general payments reported to CMS, 2019-2025
18 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $167 · 2021: $95.95 · 2022: $34.68 · 2023: $61.63 · 2024: $79.46 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $188.58 | 2019-2025 | Nucala |
| Insmed, INC. | $151.39 | 2019-2025 | Brinsupri, Arikayce |
| Grifols USA, LLC | $118.89 | 2021-2025 | Prolastin-C Liquid |
| Ethicon INC. | $115.16 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $79.05 | 2021-2025 | Fasenra |
| Amgen INC. | $60.52 | 2024-2025 | Tezspire |
| Electromed, INC. | $59.37 | 2024 | Smartvest |
| Genentech USA, INC. | $53.63 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $39.74 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $22.69 | 2019 | |
| Boston Scientific Corporation | $21.12 | 2025 | Watchman Flx |
| Medtronic, INC. | $20.49 | 2025 | Illumisite |
| Philips North America LLC | $18.19 | 2023 | |
| Pfizer INC. | $16.13 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.75 | 2023 | Glassia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hospira, INC. | $15.50 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.